Cellular Biology of Addiction
August 8 - 14, 2017
Application Deadline: April 30, 2017


David Belin, University of Cambridge, United Kingdom
Antonello Bonci, National Institute on Drug Abuse 
Christopher Evans, University of California, Los Angeles
Brigitte Kieffer, Douglas Research Centre at McGill University, Canada

See the roll of honor - who's taken the course in the past

Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated exposure to drugs produces neuroadaptation and long-term memory of the experience, but the cellular and molecular processes involved are only partially understood. The primary objective of the proposed workshop is to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to new or experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, relapse to drug use and general brain function. A range of disciplines and topics will be represented, including noninvasive brain imaging to identify drug targets and adaptive processes; neuroadaptative processes at the molecular and cellular level, neural networks and their modulation, the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cellular level and approaches to exploiting the daunting volume generated by neuroinformatics. This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration, provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavor, the information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. This workshop is designed to generate interest in this level of analysis, open conduits for collaborations and present novel routes to investigating the neurobiology of addictive drugs.

2017 Speakers:

Michael Bruchas, Washington University School of Medicine, St. Louis
Charles Chavkin
, University of Washington
Barry Everitt, University of Cambridge, United Kingdom
Peyman Golshani, University of California School of Medicine
Peter Kalivas
, Medical University of South Carolina
Hedy Kober, Yale University
Angus Nairn,
Yale University
Eric Nestler, 
Mount Sinai University
Marina Picciotto
, Yale University
Garret Stuber, University of North Carolina
Roger Sunahara, University of California, San Diego 

The course will be held at the Laboratory’s Banbury Conference Center located on the north shore of Long Island. All participants stay within walking distance of the Center.

This course will be partially supported with funds provided by the US National Institute of Drug Abuse. Scholarship funds are available for partial support of tuition, room and board on a merit basis. Substantial scholarship funds are available for partial support of tuition, room and board on a merit basis. Please apply in writing when you apply stating the need for financial aid.

Cost (including board and lodging): $2,655

This button links to a short form which confirms your interest in the course. No fees are due until you have completed the full application process and are accepted into the course.

Students accepted into the course should plan to arrive on the evening of August 7, and depart by lunchtime on August 14